Aynur Ünalp
55 works · 6,233 citations · h-index 18
Top works
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
- Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD)
- Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis
- Relationship of steatosis grade and zonal location to histological features of steatohepatitis in adult patients with non-alcoholic fatty liver disease
- Pioglitazone versus vitamin E versus placebo for the treatment of non-diabetic patients with non-alcoholic steatohepatitis: PIVENS trial design
- Effects of Liver Biopsy Sample Length and Number of Readings on Sampling Variability in Nonalcoholic Fatty Liver Disease
- Smoking and severity of hepatic fibrosis in nonalcoholic fatty liver disease
- Quality of life in adults with nonalcoholic fatty liver disease
- Generalizability of the Nonalcoholic Steatohepatitis Clinical Research Network Histologic Scoring System for Nonalcoholic Fatty Liver Disease
- Hedgehog pathway activation parallels histologic severity of injury and fibrosis in human nonalcoholic fatty liver disease
- Treatment of nonalcoholic fatty liver disease in children: TONIC trial design
- Gender Representation in Trials
- Correlation of Vitamin E, Uric Acid, and Diet Composition With Histologic Features of Pediatric NAFLD
- Symptoms and quality of life in obese children and adolescents with non‐alcoholic fatty liver disease
- Coffee consumption in NAFLD patients with lower insulin resistance is associated with lower risk of severe fibrosis
- Costaining for keratins 8/18 plus ubiquitin improves detection of hepatocyte injury in nonalcoholic fatty liver disease
- High prevalence of hypercoagulable states in patients with recurrent thrombosis of mechanical heart valves.
- Chemoprevention for Barrett’s Esophagus Trial. Design and outcome measures
- Presentation in relation to publication of results from clinical trials
- FDA Censoring of Manufacturersʼ Postmarketing Commitments in HIV/AIDS Drug Approval Letters